Research peptides,
measured not marketed.
Pepmol supplies high-purity peptides and longevity compounds to UK laboratories and independent researchers. Every vial is traceable to a batch, and every batch to a certificate of analysis.
Not sure where to begin? The consultation asks five questions about your research objective and returns a shortlist with the reasoning shown.
Categories
Metabolic Research
Compounds studied in models of glucose handling, appetite signalling and adiposity.
Regenerative & Repair
Peptides investigated for tissue repair, connective tissue and gut barrier models.
Longevity & Cellular
Senescence, mitochondrial and telomere-adjacent research compounds.
Cognitive & Neuro
Nootropic and neurotrophic research peptides.
Growth Factor Research
Secretagogue and growth-axis research compounds.
Dermal & Cosmetic
Peptides studied in collagen, pigmentation and dermal models.
Tell us the research question. We'll narrow the shelf.
Five questions on objective, familiarity, format and budget. You get a shortlist of three to five compounds with the literature rationale for each — and no medical advice, ever.
Featured compounds
BPC-157 5mg
Pentadecapeptide studied extensively in tissue repair models.
- Presentation
- 5mg lyophilised vial
- Form
- Lyophilised powder
TB-500 (Thymosin Beta-4) 5mg
Actin-binding peptide fragment used in cell migration research.
- Presentation
- 5mg lyophilised vial
- Form
- Lyophilised powder
Semaglutide 3mg
GLP-1 receptor agonist for metabolic research.
- Presentation
- 3mg lyophilised vial
- Form
- Lyophilised powder
Tirzepatide 5mg
Dual GIP/GLP-1 receptor agonist reference standard.
- Presentation
- 5mg lyophilised vial
- Form
- Lyophilised powder
Reading
How to read a certificate of analysis
Purity percentages, HPLC traces and mass spec confirmation — what each section of a COA actually tells you.
Reconstitution and storage in the laboratory
Bacteriostatic water, diluent volumes and cold-chain handling for lyophilised research peptides.
The GLP-1 research landscape in 2026
Where incretin research has moved since the first dual agonists, and what comparators labs are using now.